MTOR and cancer: Mechanistic target of rapamycin (mTOR), a serine/threonine protein kinase that is ubiquitously expressed in mammalian cancer, is classified into two complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), and these complexes have distinct roles in cells [32].